Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

EGFR helps protect hair follicles from bacterial infections.

This review highlights that long-term health consequences of COVID-19, affecting multiple body systems, persist after acute infection, necessitating a comprehensive management approach that includes interdisciplinary care and lifestyle interventions to mitigate long-term damage.

This study found that both primary Covid-19 infections and exacerbations of existing health conditions influence mortality, with long-term effects being predictable from GLM models.

This review discusses the dual effects of sporting activities on skin health, highlighting potential risks like skin diseases and benefits such as improved outcomes in chronic skin conditions, but reports no new clinical results.

This paper reviews the links between COVID-19 infection and cutaneous, oral, and periodontal lesions but reports no new clinical findings.

This article criticizes Hiner and Walters' omission of HIV and other sexually transmitted infections as potential causes of chronic diarrhea and emphasizes the importance of taking a sexual history.

Werner's syndrome causes early aging and increases cancer risk, requiring early diagnosis and symptom management.

This article discusses cosmetic surgeries offered to men in the UK and highlights potential risks but reports no new findings.

This report details the first two cancer patients with COVID-19 and co-infection cases at the Instituto Nacional de Cancerología, ESE, and presents their clinical symptoms and complications.

This analysis reports that hepatitis B surface protein antigen exposure is associated with an increased risk of alopecia areata.

This case report describes the successful topical treatment of a horse with a Pythium insidiosum infection using amphotericin B and DMSO, leading to significant wound healing and hair regrowth.

In this study, researchers identified a causal link between Epstein-Barr virus infection and clear cell renal cell carcinoma, highlighting GBP1 as a key target and suggesting finasteride as a potential inhibitor, offering a new direction for treatment strategies.

This case study reported rare alopecia resulting from a hyaluronic acid filler injection, noting approximately 80% hair regrowth after treatment with topical minoxidil.

This study found that complete COVID-19 vaccination significantly reduces the risk of developing long COVID symptoms, with factors like age, female gender, and obesity increasing persistence of symptoms.

This study found that patients receiving PRP treatments for various types of alopecia and skin rejuvenation had a higher risk of adverse events and lower self-assessment scores when injections were administered at shallower depths, with significant correlations between patient and physician assessments across different indications.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

This literature review observed that patients with thrombophilic conditions may experience distinct and more severe Long COVID symptoms, potentially linked to chronic hypercoagulation post-COVID-19 infection.

In this review, experts discuss the low but significant risk of serious eye complications from popular minimally invasive cosmetic procedures like fillers and botulinum toxin injections, underscoring the need for awareness, careful patient selection, and adherence to safe practices to help prevent these outcomes.

A woman's hair loss was caused by her husband's testosterone gel and a diabetic man's nail disease led to bone infection, both treated successfully.

This study reports a case of dermatophytosis, a zoonotic fungal infection, in an eleven-month-old spayed female dog, characterized by alopecia on the neck and ear, highlighting the condition's prevalence in hot, humid climates.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

This source outlines the potential effects of treatments commonly used in trichology on SARS-CoV-2 infection and offers a guide for managing trichological patients during the COVID-19 era, addressing the challenges of safely visiting and treating patients.

This study reported that age and diabetes are major factors influencing trichilemmal cyst development and size, highlighting the importance of these conditions for risk assessment and surgical planning.

This article reviews the use of cyclophosphamide in kidney disease treatment, highlighting significant concerns about long-term risks of cancer and infertility, and stress strategies for dose reduction and side effect mitigation; no new study results are presented.

This article reviews current research on the link between COVID-19 and alopecia areata, suggesting COVID-19 may increase the risk of autoimmune diseases, including alopecia, especially in those over 40, and discusses potential mechanisms and treatment options.

Women treated with X-ray for scalp fungus as children had a higher chance of hair loss, especially with higher radiation doses and severe fungus infections.

In this retrospective cohort study, researchers found that Taiwanese mothers with atopic dermatitis face higher risks of various pregnancy complications, such as premature labor and preeclampsia, while their children have increased risks of conditions like asthma and ADHD compared to mothers without atopic dermatitis.

This review discusses symptom-driven treatment approaches for PCOS, focusing on ovulation induction, androgen reduction, and weight management, and reports recent advances like recombinant FSH and GnRH-agonist protocols without providing new clinical results.

This review discusses factors contributing to COVID-19 severity disparities, highlighting age, comorbidities, race/ethnicity, and gender, and reports no new clinical findings; it emphasizes understanding these mechanisms to address risk differences.

This systematic review reports that "COVID toes" and other skin manifestations can be initial signs of COVID-19, and advises immunosuppressive therapy adjustments only for infected or at-risk patients.